Beverly C Handy Selected Research

Beverly C Handy Research Topics

4	Neoplasms (Cancer) 01/2024 - 02/2005
4	Breast Neoplasms (Breast Cancer) 09/2014 - 07/2009
2	Ovarian Neoplasms (Ovarian Cancer) 01/2024 - 01/2024
2	Neoplasm Metastasis (Metastasis) 01/2013 - 08/2010
2	Circulating Neoplastic Cells 08/2010 - 07/2009
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2005 - 02/2005
1	Prostatic Neoplasms (Prostate Cancer) 01/2018
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2005
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 02/2005
1	Lymphoma (Lymphomas) 02/2005
1	Paraproteinemias (Monoclonal Gammopathy) 02/2005
1	B-Cell Lymphoma (Lymphoma, B Cell) 02/2005
1	T-Cell Lymphoma (Lymphoma, T Cell) 02/2005
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2005
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 02/2005
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 02/2005

3	AntigensIBA 01/2024 - 01/2018
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 08/2010 - 07/2009
2	ParaproteinsIBA 04/2005 - 02/2005
2	Immunoglobulin M (IgM)IBA 04/2005 - 02/2005
1	OsteopontinIBA 01/2024
1	AutoantibodiesIBA 01/2024
1	Complement System Proteins (Complement)IBA 01/2024
1	Biomarkers (Surrogate Marker)IBA 01/2024
1	Untranslated RNA (Noncoding RNA)IBA 01/2018
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2013
1	Bevacizumab (Avastin)FDA Link 06/2011
1	Lapatinib (GW572016)FDA Link 06/2011
1	Trastuzumab (Herceptin)FDA Link 06/2011
1	human ERBB2 proteinIBA 06/2011
1	Epidermal Growth Factor (EGF)IBA 06/2011

3	Therapeutics 09/2014 - 07/2009
1	Combination Drug Therapy (Combination Chemotherapy) 06/2011
1	Drug Therapy (Chemotherapy) 06/2011